Robert Paridaens is a scholar working on Oncology, Genetics and Cancer Research.
According to data from OpenAlex, Robert Paridaens has authored 307 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Oncology, 124 papers in Genetics and 122 papers in Cancer Research. Recurrent topics in Robert Paridaens's work include Estrogen and related hormone effects (114 papers), Breast Cancer Treatment Studies (100 papers) and Cancer Treatment and Pharmacology (78 papers). Robert Paridaens is often cited by papers focused on Estrogen and related hormone effects (114 papers), Breast Cancer Treatment Studies (100 papers) and Cancer Treatment and Pharmacology (78 papers). Robert Paridaens collaborates with scholars based in Belgium, United Kingdom and Netherlands. Robert Paridaens's co-authors include Martine Piccart, Hans Wildiers, Patrick Neven, Marie-Rose Christiaens, Aron Goldhirsch, Beat Thürlimann, Luc Dirix, Laura Biganzoli, L. Mauriac and Ignace Vergote and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.
In The Last Decade
Robert Paridaens
297 papers
receiving
9.6k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98
2007693 citationsAlan S. Coates, Aparna Keshaviah et al.Journal of Clinical Oncologyprofile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
Countries citing papers authored by Robert Paridaens
Since
Specialization
Citations
This map shows the geographic impact of Robert Paridaens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Paridaens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Paridaens more than expected).
Fields of papers citing papers by Robert Paridaens
This network shows the impact of papers produced by Robert Paridaens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Paridaens. The network helps show where Robert Paridaens may publish in the future.
Co-authorship network of co-authors of Robert Paridaens
This figure shows the co-authorship network connecting the top 25 collaborators of Robert Paridaens.
A scholar is included among the top collaborators of Robert Paridaens based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Robert Paridaens. Robert Paridaens is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Markopoulos, Christos, Hein Putter, Annette Hasenburg, et al.. (2011). Age Specific Competing Mortality In Breast Cancer Patients - a TEAM Study Analysis. Data Archiving and Networked Services (DANS).
5.
Vandorpe, T., Hans Wildiers, Anne-Sophie Dieudonné, et al.. (2010). THE POSITIVE ASSOCIATION BETWEEN BREAST TUMOR SIZE AND LYMPH NODE INVOLVEMENT IN LOBULAR BREAST CANCERS IS PROGESTERONE RECEPTOR DEPENDENT. Annals of Oncology. 21. 31–32.2 indexed citations
Smeets, Ann, et al.. (2009). PREDICTING LYMPH NODE INVOLVEMENT OF BREAST CANCER BY USING GENE EXPRESSION PROFILES. Annals of Oncology. 20. 41–42.1 indexed citations
Lecomte, Pascal, Martine Berlière, Fabrice Branle, et al.. (2006). Extended adjuvant letrozole following five years of tamoxifen is cost-effective from a Belgian health care payer's perspective. Ghent University Academic Bibliography (Ghent University).3 indexed citations
12.
Mieghem, Tim Van, Karin Leunen, Nathalie Pochet, et al.. (2006). The influence of body composition and hormone replacement therapy (HRT) on progesterone receptor (PR) expression in postmenopausal women with an oestrogen receptor (ER)-positive breast cancer. International Journal of Gynecological Cancer. 16(2). 589–598.3 indexed citations
13.
Morales, Leilani, Patrick Neven, D. Timmerman, et al.. (2003). Prospective study on the effect of endocrine treatments on menopausal symptoms in breast cancer patients. Breast Cancer Research and Treatment. 82. 106–106.1 indexed citations
14.
Atalay, G., Laura Biganzoli, Françoise Renard, et al.. (2002). Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era. UCL Discovery (University College London).1 indexed citations
15.
Paridaens, Robert, J. Wildiers, Herlinde Dumez, et al.. (2002). Impact of dose-intensity of adjuvant CMF on disease-free (DFS) and overall survival (OS) in breast cancer (BC): a retrospective analysis. Annals of Oncology. 13. 45–45.8 indexed citations
16.
Wynendaele, Wim, Rita Derua, Marc Hoylaerts, et al.. (1998). Vascular endothelial growth factor (VEGF): Plasma is the place to be. Annals of Oncology. 9. 122–122.2 indexed citations
17.
Claeys, Patricia, et al.. (1998). Het effect van zelfzorginstructie op zelfzorgkennis en zelfzorggedrag bij vermoeidheid na radiotherapie en chemotherapie. 2. 51–61.1 indexed citations
18.
Razavi, Darius, et al.. (1989). Psychosocial correlates of estrogen and progesterone receptors in breast cancer. Acta Clinica Belgica. 75.1 indexed citations
19.
Mouridsen, H.T. & Robert Paridaens. (1988). Advanced breast cancer. New approaches to treatment. European Journal of Cancer. 24. 99–105.1 indexed citations
20.
Kiss, Róbert, Yvan de Launoit, M. L’Hermite, et al.. (1987). Effect of prolactin and estradiol administration on the cell proliferation in the uterus and the MXT mouse mammary neoplasm. JNCI Journal of the National Cancer Institute. 78. 983–998.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.